Abstract

This Core provides expertise and capability in the use of a variety of animal models for evaluation of lead compounds for anti-cancer activity, as well as, for support in studies of the uptake, transport and metabolism of the analogs in earlier phase studies.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program--Cooperative Agreements (U19)
Project #
5U19CA087525-04
Application #
6611137
Study Section
Special Emphasis Panel (ZCA1)
Project Start
2002-07-11
Project End
2003-05-31
Budget Start
Budget End
Support Year
4
Fiscal Year
2002
Total Cost
Indirect Cost

  Institution

Name
Emory University
Department
Type
DUNS #
042250712
City
Atlanta
State
GA
Country
United States
Zip Code
30322

  Publications

Acker, Timothy M; Khatri, Alpa; Vance, Katie M et al. (2013) Structure-activity relationships and pharmacophore model of a noncompetitive pyrazoline containing class of GluN2C/GluN2D selective antagonists. J Med Chem 56:6434-56
Symolon, Holly; Bushnev, Anatoliy; Peng, Qiong et al. (2011) Enigmol: a novel sphingolipid analogue with anticancer activity against cancer cell lines and in vivo models for intestinal and prostate cancer. Mol Cancer Ther 10:648-57
Pruett, Sarah T; Bushnev, Anatoliy; Hagedorn, Kerri et al. (2008) Biodiversity of sphingoid bases (""sphingosines"") and related amino alcohols. J Lipid Res 49:1621-39
Wang, Hongtao; Maurer, Barry J; Liu, Yong-Yu et al. (2008) N-(4-Hydroxyphenyl)retinamide increases dihydroceramide and synergizes with dimethylsphingosine to enhance cancer cell killing. Mol Cancer Ther 7:2967-76
Morales, Pablo R; Dillehay, Dirck L; Moody, Steven J et al. (2007) Safingol toxicology after oral administration to TRAMP mice: demonstration of safingol uptake and metabolism by N-acylation and N-methylation. Drug Chem Toxicol 30:197-216
Dougherty, Ann M; McDonald, Frank E; Liotta, Dennis C et al. (2006) Synthesis of 1-deoxysphingosine derivatives with conformationally restricted pyrrolidinediol head groups. Org Lett 8:649-52
Zheng, Wenjing; Kollmeyer, Jessica; Symolon, Holly et al. (2006) Ceramides and other bioactive sphingolipid backbones in health and disease: lipidomic analysis, metabolism and roles in membrane structure, dynamics, signaling and autophagy. Biochim Biophys Acta 1758:1864-84
Wiseman, John M; McDonald, Frank E; Liotta, Dennis C (2005) 1-Deoxy-5-hydroxysphingolipids as new anticancer principles: an efficient procedure for stereoselective syntheses of 2-amino-3,5-diols. Org Lett 7:3155-7
Symolon, Holly; Schmelz, Eva M; Dillehay, Dirck L et al. (2004) Dietary soy sphingolipids suppress tumorigenesis and gene expression in 1,2-dimethylhydrazine-treated CF1 mice and ApcMin/+ mice. J Nutr 134:1157-61
Sullards, M C; Wang, E; Peng, Q et al. (2003) Metabolomic profiling of sphingolipids in human glioma cell lines by liquid chromatography tandem mass spectrometry. Cell Mol Biol (Noisy-le-grand) 49:789-97

Showing the most recent 10 out of 11 publications